Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eaton Corporation plc (ETN) vs Medpace Holdings Inc (MEDP) Price & Performance

Eaton Corporation plcTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Eaton Corporation plc vs Medpace Holdings Inc — how do they compare? Eaton Corporation plc trades at $395.34 (market cap $160.31B), while Medpace Holdings Inc trades at $539.75 (market cap $15.11B). The key difference: Eaton Corporation plc is far larger — about 10.6× Medpace Holdings Inc's market cap, and Eaton Corporation plc pays a 1.07% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

ETNMEDP
Market Cap
$160.31B$15.11B
Sector
TechnologyTechnology
52-Week High
$435.78$620.59
52-Week Low
$315.82$308.88
Enterprise Value
$181.40B$14.58B
Dividend Yield
1.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eaton Corporation plc

Eaton (ETN) trades at $395.5, down 4.82% over 24 hours, but remains near its 52-week high. The stock shows a bullish technical trend with strong moving averages and support at $392. Fundamentally, the company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $2.81 exceeding the $2.73 estimate. Revenue for 2025 reached $27.45 billion, with a net income margin of 13.99%. Analyst sentiment is overwhelmingly positive, with a consensus price target of $449.50 and 64.1% of analysts rating it a Buy.

The outlook for ETN is favorable, driven by strong demand in data center power infrastructure and recent strategic acquisitions. However, risks include elevated valuation multiples like a P/E of 40.4 and potential macroeconomic pressures on industrial spending. The stock offers upside to the consensus target but requires monitoring of execution on growth initiatives and competitive dynamics in the power management sector.

Medpace Holdings Inc

MEDP trades at $539.39, up 0.6% today, with a bullish technical outlook supported by moving averages and a neutral RSI. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results pending. Revenue grew to $2.53B in 2025, and net income margins remain strong at 17.19%, though valuation ratios like P/E of 33.31 suggest premium pricing. Recent news highlights volatility and a class action lawsuit filed in June 2026.

Outlook: MEDP shows robust profitability and growth potential, but high valuations and legal risks warrant caution. Analyst consensus is mixed with a $497 price target below current levels, indicating limited upside. Key catalysts include Q2 2026 earnings on July 22, 2026, which could drive momentum if results exceed expectations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Eaton Corporation plc

Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.

Read more on ETN

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP